INO
INOVIO PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.24
+2.48%Next report
Analyst consensus
- Next report date
- Nov 10, 2026
- EPS estimate
- -$0.20
- Revenue estimate
- $2.3M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.07
- EPS estimate
- -$0.22
- Revenue actual
- —
- Revenue estimate
- $533.3K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +66.0%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $3.50
- PT range
- $3.00 – $4.00
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.22 | -$0.07 | Beat 67.69% | — |
| May 13, 2026 | -$0.30 | -$0.28 | Beat 6.67% | — |
| Mar 12, 2026 | -$0.36 | $0.31 | Beat 186.59% | -$65.3K |
| Aug 12, 2025 | -$0.63 | -$0.61 | Beat 3.17% | — |
| Mar 18, 2025 | -$0.87 | -$0.69 | Beat 20.69% | $117.0K |
| Nov 14, 2024 | -$1.20 | -$0.89 | Beat 25.83% | — |
| Aug 8, 2024 | -$1.15 | -$1.19 | Miss -3.48% | $100.8K |
| Mar 6, 2024 | -$1.27 | -$1.12 | Beat 11.81% | $102.7K |
| Nov 9, 2023 | -$1.56 | -$1.08 | Beat 30.77% | $388.4K |
| May 10, 2023 | -$1.68 | -$1.92 | Miss -14.29% | $114.9K |
| Mar 1, 2023 | -$1.92 | -$2.52 | Miss -31.25% | $124.7K |
| Mar 1, 2022 | -$3.96 | -$6.00 | Miss -51.52% | $839.1K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 10, 2026